"He went against the tide of all public health theses": Didier Raoult, the fallen idol

For the first time, he backed down. Didier Raoult announced on June 2, a few days after the Assistance publique-Hôpitaux de Marseille, that he and his co-authors would retract a study on 30,000 patients published on April 4 in preprint (without peer review). It intended to reaffirm the effectiveness of hydroxychloroquine against Covid-19, a little more than three years after the first thunderous outings of the microbiologist. He backed off... but very partially. On hydroxychloroquine, associated or not with other products, he remains straight in his boots despite a now indisputable scientific consensus on the ineffectiveness of the product and its risks of toxicity in Covid, especially associated with azithromycin.

The former director of the IHU Méditerranée Infection, in Marseille, does not regret his assertions at the very beginning of the pandemic, when very preliminary results encouraged to test the molecule, but did not allow to proclaim its effectiveness

This article is for subscribers only. You still have 92% to discover.

Want to read more?

Unblock all items immediately.

TEST FOR 0,99€

Already a subscriber? Log